Pharma Journalist 8791 posts 0 comments

GeneQuine Biotherapeutics GmbH, a biotech company focused on the development of gene therapy for musculoskeletal disorders, announced that it has contracted Exothera S.A., a…
Read More...

The Phase 3 PEGASUS trial evaluating rilzabrutinib to treat pemphigus, a rare autoimmune skin condition, did not meet its primary or key secondary endpoints. Rilzabrutinib’s safety…
Read More...

Repligen Corporation a life sciences company focused on bioprocessing technology leadership, and Navigo Proteins GmbH (“Navigo”), announced they have completed development and…
Read More...

Humanigen, Inc. a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm,’ announced the U.S. FDA has declined its…
Read More...

Frontage Shanghai announced the acquisition of 70% equity interest in Wuhan Heyan Biomedical Technology Co., Ltd. ("Heyan Biotech") Heyan Biotech, located in Wuhan Optics Valley,…
Read More...

Virios Therapeutics, Inc. a clinical-stage biotechnology company focused on advancing novel, combination antiviral therapies to treat debilitating chronic diseases, announced that the…
Read More...

Recro Pharma, Inc. a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges in small molecule therapeutic…
Read More...

National Resilience, Inc. (Resilience), a company seeking to build the world’s most advanced biopharmaceutical manufacturing ecosystem, and Moderna, Inc. a biotechnology company…
Read More...

Sanofi has entered into a definitive merger agreement with Kadmon Holdings, Inc. a biopharmaceutical company that discovers, develops, and markets transformative therapies for disease…
Read More...

SMi Group reports: ahead of the Oligonucleotide Therapeutics and Delivery, SMi caught up with Conference Chair Nagy Habib, Imperial College London. The Oligonucleotide Therapeutics…
Read More...